search
Back to results

Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle (COS)

Primary Purpose

Pancreatic Neoplasm

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
EUS guided FNA and fine needle punction
Sponsored by
Universitätsklinikum Hamburg-Eppendorf
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Pancreatic Neoplasm focused on measuring fine needle aspiration, core biopsy, endoscopic ultrasound, space occupying process mediastinal, perigastral, perihilar, suspect lymph nodes mediastinal, perigastral or perihilar, diagnostic accuracy of EUS guided core biopsy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • clinical indication for endoscopic ultrasound diagnostics with fine needle biopsies
  • age greater than 18 years

Exclusion Criteria:

  • difficult or impossible approach to desired structures due to anatomy (postoperative anatomy, e.g.)
  • cystic lesion, e.g. cystic pancreas tumors
  • coagulopathy
  • severe general condition of the patient
  • other contraindications for endoscopical ultrasound aided fine needle punction

Sites / Locations

  • Universitätsklinikum Hamburg-Eppendorf

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

EUS guided FNA and fine needle punction

Arm Description

punction of endosonographically identified space-occupying process with aspirating fine needle and pro core fine needle in a randomized order

Outcomes

Primary Outcome Measures

Diagnostic Accuracy
Diagnostic accuracy of Pro-core needle (22 G) will be compared to conventional fine needle aspiration (22 G). Therefore EUS-FNA with both needles is undertaken in a random order in each lesion. For Pro-core needle, a histological / cytological diagnosis and quality assessment will be made by pathologists.For Echotip aspiration needle, reference cytology evaluation is done by cytology experts. The histopathological diagnosis after surgery or the clinical follow up of at least one year after EUS FNA is current standard.

Secondary Outcome Measures

EUS Pro Core FNA: Histology Samples
Histology (not cytology) samples for Pro-core Needle: Number of adequately evaluable histology samples
Complication Rates
Complication rates of EUS FNA

Full Information

First Posted
July 8, 2013
Last Updated
June 5, 2019
Sponsor
Universitätsklinikum Hamburg-Eppendorf
search

1. Study Identification

Unique Protocol Identification Number
NCT02181140
Brief Title
Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle
Acronym
COS
Official Title
Prospective Evaluation of the Significance of the Pro-core® Needle in Differential Diagnosis of Tumorous and Inflammatory Processes
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
August 2011 (undefined)
Primary Completion Date
October 2014 (Actual)
Study Completion Date
October 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universitätsklinikum Hamburg-Eppendorf

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study is designed to evaluate the diagnostic accuracy of a new designed endoscopic ultrasonography (EUS) Core biopsy aspiration needle in comparison to a conventional EUS aspiration needle in GI-tumors.
Detailed Description
Endoscopic ultrasound is an established examination method for tumors of the gastrointestinal tract and the pancreas. Since imaging by itself is limited in differential diagnosis of tumors, EUS guided fine needle aspiration is seen as a valid complementary method. Since fine-needle aspiration (FNA) is mainly based on cytological diagnostics, this method is limited also because of lacking supplementary immune- histochemical diagnostics. Here, the obtainment of little histologically evaluable tissue samples (punched barrels) would be of benefit. A new punch needle device called Pro-core needle (Cook)(22 / 19 gauges) offers the possibility of increasing numbers of valid extractions of histologically evaluable tissues due to a better targeted precision and maneuverability in comparison to other devices of that kind (tru-cut needles, e.g.). A little notch at the pinpoint allows the obtainment of little tissue samples, that will be kept within the device by aspiration. This study compares the obtainment of tissue by Proc-core needle and conventional aspiration punction systems.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pancreatic Neoplasm
Keywords
fine needle aspiration, core biopsy, endoscopic ultrasound, space occupying process mediastinal, perigastral, perihilar, suspect lymph nodes mediastinal, perigastral or perihilar, diagnostic accuracy of EUS guided core biopsy

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
56 (Actual)

8. Arms, Groups, and Interventions

Arm Title
EUS guided FNA and fine needle punction
Arm Type
Other
Arm Description
punction of endosonographically identified space-occupying process with aspirating fine needle and pro core fine needle in a randomized order
Intervention Type
Device
Intervention Name(s)
EUS guided FNA and fine needle punction
Intervention Description
punction of a suspect area by a EUS guided fine needle as well as pro core fine needle to evacuate histology and smear biologics
Primary Outcome Measure Information:
Title
Diagnostic Accuracy
Description
Diagnostic accuracy of Pro-core needle (22 G) will be compared to conventional fine needle aspiration (22 G). Therefore EUS-FNA with both needles is undertaken in a random order in each lesion. For Pro-core needle, a histological / cytological diagnosis and quality assessment will be made by pathologists.For Echotip aspiration needle, reference cytology evaluation is done by cytology experts. The histopathological diagnosis after surgery or the clinical follow up of at least one year after EUS FNA is current standard.
Time Frame
up to 1 year
Secondary Outcome Measure Information:
Title
EUS Pro Core FNA: Histology Samples
Description
Histology (not cytology) samples for Pro-core Needle: Number of adequately evaluable histology samples
Time Frame
day 0 and day 14
Title
Complication Rates
Description
Complication rates of EUS FNA
Time Frame
day 0 and day 14

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: clinical indication for endoscopic ultrasound diagnostics with fine needle biopsies age greater than 18 years Exclusion Criteria: difficult or impossible approach to desired structures due to anatomy (postoperative anatomy, e.g.) cystic lesion, e.g. cystic pancreas tumors coagulopathy severe general condition of the patient other contraindications for endoscopical ultrasound aided fine needle punction
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas Rösch, Prof. Dr.
Organizational Affiliation
University Hospital Eppendorf, Hamburg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universitätsklinikum Hamburg-Eppendorf
City
Hamburg
ZIP/Postal Code
20246
Country
Germany

12. IPD Sharing Statement

Citations:
PubMed Identifier
20815858
Citation
Parikh P, Shiloach M, Cohen ME, Bilimoria KY, Ko CY, Hall BL, Pitt HA. Pancreatectomy risk calculator: an ACS-NSQIP resource. HPB (Oxford). 2010 Sep;12(7):488-97. doi: 10.1111/j.1477-2574.2010.00216.x.
Results Reference
background
PubMed Identifier
20071702
Citation
van der Gaag NA, Rauws EA, van Eijck CH, Bruno MJ, van der Harst E, Kubben FJ, Gerritsen JJ, Greve JW, Gerhards MF, de Hingh IH, Klinkenbijl JH, Nio CY, de Castro SM, Busch OR, van Gulik TM, Bossuyt PM, Gouma DJ. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010 Jan 14;362(2):129-37. doi: 10.1056/NEJMoa0903230.
Results Reference
background
PubMed Identifier
19394012
Citation
Moller K, Papanikolaou IS, Toermer T, Delicha EM, Sarbia M, Schenck U, Koch M, Al-Abadi H, Meining A, Schmidt H, Schulz HJ, Wiedenmann B, Rosch T. EUS-guided FNA of solid pancreatic masses: high yield of 2 passes with combined histologic-cytologic analysis. Gastrointest Endosc. 2009 Jul;70(1):60-9. doi: 10.1016/j.gie.2008.10.008. Epub 2009 Apr 25.
Results Reference
background
PubMed Identifier
15672060
Citation
Takahashi K, Yamao K, Okubo K, Sawaki A, Mizuno N, Ashida R, Koshikawa T, Ueyama Y, Kasugai K, Hase S, Kakumu S. Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA. Gastrointest Endosc. 2005 Jan;61(1):76-9. doi: 10.1016/s0016-5107(04)02224-2.
Results Reference
background
PubMed Identifier
17226911
Citation
Iglesias-Garcia J, Dominguez-Munoz E, Lozano-Leon A, Abdulkader I, Larino-Noia J, Antunez J, Forteza J. Impact of endoscopic ultrasound-guided fine needle biopsy for diagnosis of pancreatic masses. World J Gastroenterol. 2007 Jan 14;13(2):289-93. doi: 10.3748/wjg.v13.i2.289.
Results Reference
background
PubMed Identifier
15483756
Citation
Sudhoff T, Hollerbach S, Wilhelms I, Willert J, Reiser M, Topalidis T, Schmiegel W, Graeven U. [Clinical utility of EUS-FNA in upper gastrointestinal and mediastinal disease]. Dtsch Med Wochenschr. 2004 Oct 15;129(42):2227-32. doi: 10.1055/s-2004-831867. German.
Results Reference
background
PubMed Identifier
17620230
Citation
Aithal GP, Anagnostopoulos GK, Tam W, Dean J, Zaitoun A, Kocjan G, Ragunath K, Pereira SP. EUS-guided tissue sampling: comparison of "dual sampling" (Trucut biopsy plus FNA) with "sequential sampling" (Trucut biopsy and then FNA as required). Endoscopy. 2007 Aug;39(8):725-30. doi: 10.1055/s-2007-966400. Epub 2007 Jul 10.
Results Reference
background
PubMed Identifier
16417562
Citation
Wittmann J, Kocjan G, Sgouros SN, Deheragoda M, Pereira SP. Endoscopic ultrasound-guided tissue sampling by combined fine needle aspiration and trucut needle biopsy: a prospective study. Cytopathology. 2006 Feb;17(1):27-33. doi: 10.1111/j.1365-2303.2006.00313.x.
Results Reference
background
PubMed Identifier
18648133
Citation
Shah SM, Ribeiro A, Levi J, Jorda M, Rocha-Lima C, Sleeman D, Hamilton-Nelson K, Ganjei-Azar P, Barkin J. EUS-guided fine needle aspiration with and without trucut biopsy of pancreatic masses. JOP. 2008 Jul 10;9(4):422-30.
Results Reference
background
PubMed Identifier
17479313
Citation
Storch I, Shah M, Thurer R, Donna E, Ribeiro A. Endoscopic ultrasound-guided fine-needle aspiration and Trucut biopsy in thoracic lesions: when tissue is the issue. Surg Endosc. 2008 Jan;22(1):86-90. doi: 10.1007/s00464-007-9374-x. Epub 2007 May 4.
Results Reference
background
PubMed Identifier
16996340
Citation
Storch I, Jorda M, Thurer R, Raez L, Rocha-Lima C, Vernon S, Ribeiro A. Advantage of EUS Trucut biopsy combined with fine-needle aspiration without immediate on-site cytopathologic examination. Gastrointest Endosc. 2006 Oct;64(4):505-11. doi: 10.1016/j.gie.2006.02.056. Epub 2006 Jun 6.
Results Reference
background
PubMed Identifier
17190771
Citation
Saftoiu A, Vilmann P, Guldhammer Skov B, Georgescu CV. Endoscopic ultrasound (EUS)-guided Trucut biopsy adds significant information to EUS-guided fine-needle aspiration in selected patients: a prospective study. Scand J Gastroenterol. 2007 Jan;42(1):117-25. doi: 10.1080/00365520600789800.
Results Reference
background
PubMed Identifier
19032453
Citation
Sakamoto H, Kitano M, Komaki T, Noda K, Chikugo T, Dote K, Takeyama Y, Das K, Yamao K, Kudo M. Prospective comparative study of the EUS guided 25-gauge FNA needle with the 19-gauge Trucut needle and 22-gauge FNA needle in patients with solid pancreatic masses. J Gastroenterol Hepatol. 2009 Mar;24(3):384-90. doi: 10.1111/j.1440-1746.2008.05636.x. Epub 2008 Nov 20.
Results Reference
background
PubMed Identifier
19640524
Citation
Siddiqui UD, Rossi F, Rosenthal LS, Padda MS, Murali-Dharan V, Aslanian HR. EUS-guided FNA of solid pancreatic masses: a prospective, randomized trial comparing 22-gauge and 25-gauge needles. Gastrointest Endosc. 2009 Dec;70(6):1093-7. doi: 10.1016/j.gie.2009.05.037. Epub 2009 Jul 28.
Results Reference
background
PubMed Identifier
18937186
Citation
Jenssen C, Faiss S, Nurnberg D. [Complications of endoscopic ultrasound and endoscopic ultrasound-guided interventions - results of a survey among German centers]. Z Gastroenterol. 2008 Oct;46(10):1177-84. doi: 10.1055/s-2008-1027334. Epub 2008 Oct 20. German.
Results Reference
background
PubMed Identifier
16680633
Citation
Bournet B, Migueres I, Delacroix M, Vigouroux D, Bornet JL, Escourrou J, Buscail L. Early morbidity of endoscopic ultrasound: 13 years' experience at a referral center. Endoscopy. 2006 Apr;38(4):349-54. doi: 10.1055/s-2005-921173.
Results Reference
background
PubMed Identifier
15692930
Citation
Mortensen MB, Fristrup C, Holm FS, Pless T, Durup J, Ainsworth AP, Nielsen HO, Hovendal C. Prospective evaluation of patient tolerability, satisfaction with patient information, and complications in endoscopic ultrasonography. Endoscopy. 2005 Feb;37(2):146-53. doi: 10.1055/s-2005-861142.
Results Reference
background
PubMed Identifier
18058615
Citation
Al-Haddad M, Wallace MB, Woodward TA, Gross SA, Hodgens CM, Toton RD, Raimondo M. The safety of fine-needle aspiration guided by endoscopic ultrasound: a prospective study. Endoscopy. 2008 Mar;40(3):204-8. doi: 10.1055/s-2007-995336. Epub 2007 Dec 4.
Results Reference
background
PubMed Identifier
10205212
Citation
Williams DB, Sahai AV, Aabakken L, Penman ID, van Velse A, Webb J, Wilson M, Hoffman BJ, Hawes RH. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut. 1999 May;44(5):720-6. doi: 10.1136/gut.44.5.720.
Results Reference
background
PubMed Identifier
11275888
Citation
O'Toole D, Palazzo L, Arotcarena R, Dancour A, Aubert A, Hammel P, Amaris J, Ruszniewski P. Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc. 2001 Apr;53(4):470-4. doi: 10.1067/mge.2001.112839.
Results Reference
background
PubMed Identifier
9097990
Citation
Wiersema MJ, Vilmann P, Giovannini M, Chang KJ, Wiersema LM. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology. 1997 Apr;112(4):1087-95. doi: 10.1016/s0016-5085(97)70164-1.
Results Reference
background
PubMed Identifier
16843076
Citation
Buscarini E, De Angelis C, Arcidiacono PG, Rocca R, Lupinacci G, Manta R, Carucci P, Repici A, Carrara S, Vallisa D, Buscarini L, Cosentino F, Pera A, Rizzetto M, Testoni PA, Zambelli A. Multicentre retrospective study on endoscopic ultrasound complications. Dig Liver Dis. 2006 Oct;38(10):762-7. doi: 10.1016/j.dld.2006.06.005. Epub 2006 Jul 13.
Results Reference
background
PubMed Identifier
27818598
Citation
Sterlacci W, Sioulas AD, Veits L, Gonullu P, Schachschal G, Groth S, Anders M, Kontos CK, Topalidis T, Hinsch A, Vieth M, Rosch T, Denzer UW. 22-gauge core vs 22-gauge aspiration needle for endoscopic ultrasound-guided sampling of abdominal masses. World J Gastroenterol. 2016 Oct 21;22(39):8820-8830. doi: 10.3748/wjg.v22.i39.8820.
Results Reference
result

Learn more about this trial

Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® Needle

We'll reach out to this number within 24 hrs